Janus Henderson Group Plc - Sep 30, 2025 SCHEDULE 13G/A Report for LEXEO THERAPEUTICS, INC. Common Stock (LXEO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
LEXEO THERAPEUTICS, INC. Common Stock
Symbol
LXEO
Shares outstanding
54M shares
Disclosed Ownership
6.11M shares
Ownership
11.3%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 12:49 PM
Date of event
Sep 30, 2025
Previous filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 11.3% 6.11M 0 6.11M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 7.6% 4.08M 0 4.08M Kristin Mariani Head of North America Compliance, CCO